<unk> is a selective NMDA receptor (NMDAR) antagonist that competitively inhibits the glutamate binding site and thus activation of NMDAR. It has anticonvulsant effects.<unk> functions specifically as a NMDA recognition site blocker, in contrast with<unk> -chlorokynurenate, which acts as a glycine site modulation blocker.
AP-7 
BIM-1
BGR-34
CURB-65
CARB-X
CoWIN
P14arf
C-KAD